A radiological complete response to pembrolizumab in a patient with metastatic upper urinary tract urothelial cancer and Lynch syndrome

INTRODUCTION: In Lynch syndrome, urothelial cancer is the third most common cancer, following colorectal and endometrial cancers. Little is known, however, about the efficacy of immune checkpoint inhibitors in the treatment of metastatic urothelial cancer in Lynch syndrome. CASE PRESENTATION: A 49‐y...

Descripción completa

Detalles Bibliográficos
Autores principales: Oki, Ryosuke, Urasaki, Tetsuya, Ueki, Arisa, Inamura, Kentaro, Komai, Yoshinobu, Takahashi, Shunji, Yonese, Junji, Yuasa, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807341/
https://www.ncbi.nlm.nih.gov/pubmed/36605683
http://dx.doi.org/10.1002/iju5.12542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807341/
https://www.ncbi.nlm.nih.gov/pubmed/36605683
http://dx.doi.org/10.1002/iju5.12542

Ejemplares similares